Building oligonucleotide therapeutics using non-natural chemistries
Authors:
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 10 (6) , 607-614
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Direct PCR amplification of various modified DNAs having amino acids: Convenient preparation of DNA libraries with high-potential activities for in vitro selectionBioorganic & Medicinal Chemistry, 2006
- Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotideThe Journal of Gene Medicine, 2005
- On the in vitro and in vivo Properties of Four Locked Nucleic Acid Nucleotides Incorporated into an Anti‐H‐Ras Antisense OligonucleotideChemBioChem, 2005
- RNA interference induced by siRNAs modified with 4′‐thioribonucleosides in cultured mammalian cellsFEBS Letters, 2005
- Successful combination of local CpG‐ODN and radiotherapy in malignant gliomaInternational Journal of Cancer, 2005
- Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGFChemistry & Biology, 2005
- Morpholino antisense oligomer targeting human midkine: Its application for cancer therapyInternational Journal of Cancer, 2004
- Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA)Journal of Hepatology, 2004
- CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II StudyJournal of Clinical Immunology, 2004
- Intracellular uptake of modified oligonucleotide studied by two fluorescence techniquesBiopolymers, 2004